Gefapixant Reduces Refractory, Unexplained Cough Frequency Gefapixant Reduces Refractory, Unexplained Cough Frequency

The P2X3 receptor agonist significantly reduces chronic, unexplained cough, for which there is currently no approved treatment, findings from two randomized, placebo-controlled phase 3 trials show.Medscape Medical News

Source: Medscape Medical News Headlines - September 10, 2020 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news